NCT07619313
- Conditions
- Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Metastatic Cholangiocarcinoma
Explore clinical trials studying Metastatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
9 public trials
1 recruiting study
Metastatic Cholangiocarcinoma trial results
Active, not recruiting
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
NCT06160752
- Conditions
- Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
- Locations
-
- University of California San Francisco (UCSF) San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- The Ohio State University Columbus, Ohio, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
NCT04175912
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, not recruiting
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
NCT04068194
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, not recruiting
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
NCT06178588
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +11 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States
NCT03250273
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +19 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
Completed
Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)
NCT02989857
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +5 more
- Locations
-
- Mayo Cancer Center Scottsdale, Arizona, United States
- City of Hope Cancer Center Duarte, California, United States
- University of California, Irvine Irvine, California, United States
- University of Southern California Los Angeles, California, United States
NCT03201458
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
NCT03656536
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Marin Cancer Care Greenbrae, California, United States
- UC Irvine Medical Center Orange, California, United States
- Georgetown University-Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States